Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$63.32 USD

63.32
931,004

-0.05 (-0.08%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $63.32 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Instruments - Scientific

Better trading starts here.

Zacks News

Here's Why You Should Add Bruker (BRKR) to Your Portfolio Now

Investor confidence in Bruker (BRKR) is at a high, thanks to solid prospects.

Bruker (BRKR) Is Up 2.98% in One Week: What You Should Know

Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why the Earnings Surprise Streak Could Continue for Bruker (BRKR)

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here is Why Growth Investors Should Buy Bruker (BRKR) Now

Bruker (BRKR) possesses solid growth attributes, which could help it handily outperform the market.

Bruker (BRKR) Rides High on Strong Nano Sales, New Buyouts

Bruker (BRKR) is reaping solid synergy benefits from the acquisitions of Anasys, JPK and Alicona.

Bruker Launches Luxendo TruLive3D Imager, Expands NANO Arm (Revised)

Bruker's (BRKR) latest Luxendo TruLive3D Imager revolutionizes cell culture live imaging in natural environments.

Bruker Launches Luxendo TruLive3D Imager in Mass Spectrometry

Bruker's (BRKR) Luxendo TruLive3D Imager revolutionizes cell culture live imaging in natural environment.

Bruker (BRKR) Beats Q3 Earnings Estimates, Ups EPS Guidance

Bruker (BRKR) delivers robust third-quarter revenue growth, backed by strong segmental performances.

Bruker (BRKR) Beats Q3 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 13.16% and 5.13%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Bruker (BRKR) Earnings Expected to Grow: Should You Buy?

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker To Buy Freiberg Instruments' Magnettech EPR Business

The Freiberg Instruments' Magnettech EPR business acquisition is expected to boost Bruker's (BRKR) BioSpin business by complementing its existing range of EPR offerings.

Bruker (BRKR) Enters Into Alliance With Murdoch University

Bruker's (BRKR) collaboration with Murdoch University will support International Centre of Excellence in metabolic phenotyping.

Bruker (BRKR) Introduces the nanoIR3-s Broadband System

The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.

Bruker (BRKR) Releases JPK NanoWizard 4 XP Bio-AFM System

With the launch of this new system, Bruker (BRKR) establishes a performance yardstick for atomic force microscopy in the field of life science research.

Bruker (BRKR) Down 7.4% Since Last Earnings Report: Can It Rebound?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bruker (BRKR) Q2 Earnings Beat Estimates, Margins Expand

Bruker (BRKR) registers strong year-over-year revenue growth across all segments and geographies.

Bruker (BRKR) Beats Q2 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 6.45% and 2.71%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Garmin's (GRMN) Q2 Earnings & Revenues Surpass Estimates

Garmin's (GRMN) second-quarter results benefit from strong performance by its fitness, outdoor, marine and aviation segments.

Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?

Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.

Is Bruker (BRKR) Outperforming Other Computer and Technology Stocks This Year?

Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?

Bruker (BRKR) Earnings Expected to Grow: Should You Buy?

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Illumina (ILMN) Grows on Innovation & International Growth

Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.

NuVasive (NUVA) Launches Pulse Integrated Technology Platform

The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.

Boston Scientific's Global Growth Robust Amid Currency Woe

Boston Scientific (BSX) is currently pinning hopes on a stronger performance in China, backed by the recent approval of SYNERGY in the country.

Has Bruker (BRKR) Outpaced Other Computer and Technology Stocks This Year?

Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?